Description
20,75,073 new equity shares of Vivo Bio tech Ltd listed on BSE with effect from August 18, 2025, issued on preferential basis pursuant to warrant conversion.
Summary
BSE has announced the listing of 20,75,073 new equity shares of Vivo Bio tech Ltd (Scrip Code: 511509) with effect from Monday, August 18, 2025. These shares were issued at Rs. 45/- per share (Rs. 10/- face value + Rs. 35/- premium) to non-promoters on preferential basis pursuant to conversion of warrants.
Key Points
- Total shares listed: 20,75,073 equity shares of Rs. 10/- each
- Issue price: Rs. 45/- per share (including Rs. 35/- premium)
- Trading commencement: August 18, 2025
- Distribution numbers: 17924817 to 19999889
- ISIN: INE380K01017
- Shares rank pari-passu with existing equity shares
Regulatory Changes
No regulatory changes introduced. This is a routine listing following warrant conversion.
Compliance Requirements
All shares are subject to lock-in restrictions until February 28, 2026, across four tranches with different allotment dates.
Important Dates
- Trading commencement: August 18, 2025
- Allotment dates: May 28, 2025; June 18, 2025; June 25, 2025; July 3, 2025
- Lock-in expiry: February 28, 2026 (for all tranches)
Impact Assessment
Minimal market impact expected as this represents routine listing of shares from warrant conversion. The lock-in period until February 2026 ensures these shares cannot be traded immediately, limiting any potential dilution impact on existing shareholders.
Impact Justification
Routine listing of new shares through warrant conversion with standard lock-in period